These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17414231)

  • 21. Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.
    Saddichha S; Kumar R; Babu GN; Chandra P
    J Clin Pharmacol; 2012 Sep; 52(9):1448-9. PubMed ID: 21903892
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
    Nagoshi Y; Tominaga T; Fukui K
    J Clin Psychopharmacol; 2014 Jun; 34(3):397-8. PubMed ID: 24525655
    [No Abstract]   [Full Text] [Related]  

  • 23. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
    Sheffrin M; Driscoll HC; Lenze EJ; Mulsant BH; Pollock BG; Miller MD; Butters MA; Dew MA; Reynolds CF
    J Clin Psychiatry; 2009 Feb; 70(2):208-13. PubMed ID: 19210951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.
    Lorenz RA; Jackson CW; Saitz M
    Pharmacotherapy; 2010 Sep; 30(9):942-51. PubMed ID: 20795849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.
    Rosenthal M
    J Clin Psychiatry; 2003 Oct; 64(10):1245-9. PubMed ID: 14658975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of unexpected and selective remission of a 20-year history of ephedrine dependence following treatment with low-dose aripiprazole.
    Arnold KK; Yager J
    J Clin Psychiatry; 2007 Oct; 68(10):1620-1. PubMed ID: 17960985
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychosis in the elderly.
    Kyomen HH; Whitfield TH
    Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
    [No Abstract]   [Full Text] [Related]  

  • 29. Aripiprazole-associated acute dystonia.
    Sanghadia M; Pinninti NR
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):89-90. PubMed ID: 17308239
    [No Abstract]   [Full Text] [Related]  

  • 30. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
    Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
    J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
    [No Abstract]   [Full Text] [Related]  

  • 32. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
    J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An aripiprazole discontinuation syndrome.
    Philip NS
    R I Med J (2013); 2013 Feb; 96(2):13-4. PubMed ID: 24933746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
    Simon JS; Nemeroff CB
    J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micturition difficulty and urinary retention associated with aripiprazole and citalopram treatment in a male adolescent with Asperger syndrome.
    Yalcin O
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):598-9. PubMed ID: 24511913
    [No Abstract]   [Full Text] [Related]  

  • 36. An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
    Matthews JD; Siefert C; Dording C; Denninger JW; Park L; van Nieuwenhuizen AO; Sklarsky K; Hilliker S; Homberger C; Rooney K; Fava M
    J Clin Psychopharmacol; 2009 Feb; 29(1):73-6. PubMed ID: 19142112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.
    Masi G; Pfanner C; Millepiedi S; Berloffa S
    J Clin Psychopharmacol; 2010 Dec; 30(6):688-93. PubMed ID: 21105283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual weight fluctuation under corticosteroid and psychotropic treatment.
    Terao T
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):617-9. PubMed ID: 18950384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin syndrome: a complex but easily avoidable condition.
    Dvir Y; Smallwood P
    Gen Hosp Psychiatry; 2008; 30(3):284-7. PubMed ID: 18433663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.